Influence on Enterobacter cloacae metabolism, cell-surface hydrophobicity and motility of suprainhibitory concentrations of carbapenems

Folia Microbiologica
V Majtán, L Majtánová

Abstract

The impact of postantibiotic effect (PAE) of carbapenems (imipenem, meropenem) on the metabolism (biosynthesis of macromolecules, respiration), cell-surface hydrophobicity and motility of a clinical isolate of Enterobacter cloacae was examined. The metabolism was evaluated after 16 h and after 1 d of cultivation using 2x and 4x minimum inhibitory concentrations (MIC) of both antibiotics for the induction of PAE. Imipenem at 4 x MIC did not induce PAE. After a 16-h cultivation (in the postantibiotic phase of both carbapenems), inhibition of nucleosynthesis and protein synthesis was found; after a 1-d cultivation, during regrowth stimulation of mainly 14C-leucine incorporation was found. The presence of the exogenous intermediates of citrate cycle, viz. 2-oxoglutarate, increased the respiratory activity of the cells. The cell-surface hydrophobicity (evaluated by three methods--bacterial adhesion to hydrocarbon, nitrocellulose-filter test and salt-aggregation test) decreased after PAE of both carbapenems; meropenem was more effective. Motility (an important virulence factor) was inhibited in the postantibiotic phase of both carbapenems; the 4 x MIC caused a higher inhibition.

References

May 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G MolinariG C Schito
Sep 1, 1992·Obstetrics and Gynecology Clinics of North America·M J Dinsmoor
Oct 1, 1990·The Journal of Antimicrobial Chemotherapy·P A Majcherczyk, D M Livermore
Sep 1, 1989·The Journal of Antimicrobial Chemotherapy·H L NadlerW Sheikh
Oct 1, 1989·The Journal of Antimicrobial Chemotherapy·I M GouldK Milne
Sep 1, 1989·The Journal of Antimicrobial Chemotherapy·R C MoelleringD E Sentochnik
Sep 1, 1989·The Journal of Antimicrobial Chemotherapy·R N JonesC Thornsberry
Dec 1, 1986·The Journal of Antimicrobial Chemotherapy·R LabiaM Guionie
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·C I BustamanteH C Standiford
May 1, 1984·Infection and Immunity·R V Lachica, D L Zink
Apr 1, 1981·Canadian Journal of Microbiology·R C Craven, T C Montie
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·M GottfredssonS Gudmundsson
Oct 1, 1993·The Journal of Antimicrobial Chemotherapy·F M MacKenzie, I M Gould
Jun 1, 1993·The Journal of Antimicrobial Chemotherapy·I Odenholt-Tornqvist
May 1, 1993·Chemotherapy·M GottfredssonS Gudmundsson
Sep 3, 1998·Journal of Basic Microbiology·V Majtán, L Majtánová
Feb 1, 1997·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Inga OdenholtOtto Cars

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Seminars in Pediatric Infectious Diseases
David Schlossberg, Nancy Pietroski
Nihon rinsho. Japanese journal of clinical medicine
K Kikuchi, K Shimizu
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
H HanbergerR Maller
© 2022 Meta ULC. All rights reserved